Abeona Therapeutics (ABEO) EBT Margin (2011 - 2026)

Abeona Therapeutics' EBT Margin history runs 13 years deep, the most recent figure standing at 195.79% for Q1 2026.

• In Q1 2026, EBT Margin changed N/A year-over-year to 195.79%; the TTM figure through Mar 2026 stood at 455.56% (changed N/A YoY), while the FY2025 annual figure was 1224.79%, changed N/A from the prior year.
• EBT Margin was 195.79% for Q1 2026 at Abeona Therapeutics, up from 381.46% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 31086.25% in Q2 2025 to a low of 19285.29% in Q4 2022.
• Historically, EBT Margin has averaged 584.64% across 4 years, with a median of 381.46% in 2025.
• Biggest YoY gain for EBT Margin was 51331 bps in 2023; the steepest drop was 51331 bps in 2023.
• A 4-year view of EBT Margin shows it stood at 19285.29% in 2022, then surged by 98 bps to 304.49% in 2023, then decreased by 25 bps to 381.46% in 2025, then soared by 49 bps to 195.79% in 2026.
• The last three EBT Margin figures came in at 195.79% (Q1 2026), 381.46% (Q4 2025), and 31086.25% (Q2 2025), per Business Quant data.